The report addresses current treatments and developments since the last report, on the use of direct oral anticoagulants in patients with APS, antiplatelet ...

25 окт. 2020 г. · The report addresses current treatments and developments since the last report, on the use of direct oral anticoagulants in patients with APS, antiplatelet ...

7 нояб. 2023 г. · This task force concentrated and reviewed the literature on data including aPS/PT, antibodies to domain 4/5 of β2GPI and the newly described antibodies to ...

8 окт. 2024 г. · The 16th International Congress on Antiphospholipid Antibodies Task Force on APS Treatment Trends reviewed the current status with regard to ...

27 мая 2021 г. · 16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome. Savino ...

The 16th International Congress on Antiphospholipid Antibodies Task Force on APS Treatment Trends reviewed the current status with regard to existing and novel ...

Beyond current concepts in anti-phospholipid syndrome: The 16th International Congress on Anti-phospholipid Antibodies (ICAPA) in Manchester · Introduction.

17 июл. 2021 г. · Studies on MP in patients with antiphospholipid antibodies (aPL) are sparse and inconclusive. The risk of thrombotic events increases with the ...

The report addresses current treatments and developments since the last report, on the use of direct oral anticoagulants in patients with APS, ...

The Task Force on Catastrophic Antiphospholipid Syndrome (CAPS) met again on occasion of the 16th International Congress on Antiphospholipid Antibodies ...